• HBTU for Peptide Probe Synthesis

  2026-10-01

  HBTU provides a practical route to efficient peptide bond formation when building sequence-defined probes for immunoproteasome assays. This guide connects carboxylic acid activation, solid phase peptide synthesis, reporter installation, and assay troubleshooting while clearly separating workflow recommendations from findings reported in the reference study.

• Zoledronic Acid: Cancer and Bone Research Workflows

  2026-09-30

  Build more reproducible Zoledronic Acid studies by separating formulation, exposure, apoptosis, and bone-remodeling endpoints. This workflow supports breast cancer, multiple myeloma, and osteolytic disease models while applying orthogonal assay principles from a recent immunometabolic study.

• LMO2–LDB1 Signaling in Acute Myeloid Leukemia

  2026-09-30

  The reference study identifies an LMO2/LDB1 protein complex as a functional driver of acute myeloid leukemia (AML) cell growth, survival, and clonogenicity. By combining protein-interaction analysis, genetic perturbation, transcriptomics, and chromatin profiling, it moves LMO2 research beyond prognostic association toward a mechanistic model involving LDB1-dependent regulation of apoptosis-related genes.

• H 89 2HCl: Mapping cAMP–PKA Pain Signaling

  2026-09-29

  H 89 2HCl enables mechanistic analysis of cAMP/PKA signaling in trigeminal pain models. This article connects its biochemical selectivity and cellular limitations with the CGRP/SP–Piezo2 findings of recent nerve-root compression research to improve assay design and interpretation.

• Forskolin: Adenylate Cyclase Activator Guide

  2026-09-29

  Forskolin is a direct adenylate cyclase activator that raises intracellular cAMP and supports mechanistic studies of inflammation, neuronal signaling, stem-cell biology, and cardiovascular disease research. The B1421 product is water-insoluble and is typically prepared in DMSO for controlled in vitro experiments.

• CGK733: Reliable Cell Assay Planning

  2026-09-28

  CGK733 (SKU A8624) can be incorporated into a controlled cell-based testing workflow when compound identity, vehicle exposure, assay linearity, and biological interpretation are managed explicitly. This evidence-focused guide helps researchers evaluate CGK733 without confusing a test compound with a viability readout.

• Hexetidine and Copper: Designing Synergy Assays

  2026-09-28

  Hexetidine (NSC-17764) is more than a standalone oral antimicrobial: its interaction with copper provides a useful model for testing combination effects in oral microbiology. This article unpacks the foundational streptococcal study and turns its methods into practical assay-design decisions.

• H 89 2HCl for PKA Signaling Experiments

  2026-09-27

  Use H 89 2HCl to test whether PKA activity contributes to rapid neuronal signaling changes, including glucocorticoid-linked calcium responses. This guide connects the reference study to practical inhibitor workflows, controls, and selectivity-aware interpretation.

• Genistein Workflows for Signaling and Autophagy Research

  2026-09-26

  Use Genistein to probe growth-factor signaling and cell proliferation inhibition, while keeping its effects distinct from mechanical-stress autophagy. This guide pairs practical dose-finding and assay controls with a cautious framework for connecting kinase signaling to cytoskeleton-dependent responses.

• Etoposide (VP-16): Assays, Delivery & Optimization

  2026-09-25

  Use Etoposide (VP-16) to connect topoisomerase II–linked DNA damage with cell-death readouts, while tailoring dose and timing to the model rather than treating IC50 values as universal. A preclinical nanoparticle–hydrogel study also illustrates how etoposide research can extend from standard cell assays to localized delivery questions after brain-tumor resection.

• How the Cytoskeleton Shapes Stress-Induced Autophagy

  2026-09-25

  Liu et al. examine how cytoskeletal structures contribute to autophagy triggered by compression in human cell lines. Their results identify microfilaments as a central requirement for changes in autophagosome number, with microtubules playing an auxiliary role, sharpening the mechanistic picture of cellular responses to force.

• hiPSC Intestinal Organoids for Pharmacokinetic Studies

  2026-09-24

  Saito and colleagues describe a human iPSC-derived intestinal organoid platform designed to simplify production while preserving long-term expansion, cryopreservation, and differentiation capacity. When converted to monolayers, the organoids produced intestinal epithelial cells with drug-metabolizing enzyme and transporter activities, supporting their use in in vitro pharmacokinetic research.

• Caffeic Acid Phenethyl Ester in Neuroinflammation

  2026-09-24

  Caffeic Acid Phenethyl Ester (CAPE) offers a way to test NF-κB involvement in Fyn-driven neuroinflammation—but not to assume that pathway explains every phenotype. This article connects recent zebrafish findings to a rigorous, cell-aware assay strategy and clarifies where CAPE evidence does and does not transfer.

• Trigeminal Compression, Neuroinflammation, and Piezo2

  2026-09-23

  Liao et al. connect chronic trigeminal root compression to peripheral neuroinflammation and mechanical allodynia through a calcium-dependent CGRP/SP–Piezo2 signaling loop. Their rat and in vitro findings implicate both PKC-related regulation and cAMP-sensitive processes, while leaving the precise contribution of PKA and the pathway’s relevance to human trigeminal neuralgia open for testing.

• Defactinib and the Next Era of FAK Translation

  2026-09-23

  Defactinib offers translational researchers a way to connect FAK Tyr397 target engagement with chemoresistance, paclitaxel combinations, and phosphoproteomic strategy. This article explains how to build evidence across ovarian cancer models while using a recent Zika phosphoproteome study as a methodological, not disease-specific, guide.

526 records 1/36 page Next 12345 下5页 Last page